Cobaltic-EDTA as a marker for estimating trapped plasma
Siebers, R.W.; Shirkey, R.J.; Maling, T.J.
Clinical Chemistry 32(11): 2108
1986
ISSN/ISBN: 0009-9147 PMID: 3096604 Document Number: 268196
Document emailed within 1 workday
Related Documents
Yue, K.T.; Davis, J.W. 1982: Failure of low temperature to arrest degradation of 14C-adenosine 5'-diphosphate by human plasma in the presence of EDTA Journal of Medicine 13(1-2): 81-96Tatsumi, N.; Tsuda, I.; Fukumori, T.; Hino, M.; Takubo, T.; Kondo, H. 2001: A centrifuge-less plasma separation method from whole blood anticoagulated with EDTA-2K for the use of clinical laboratory tests Osaka city medical journal 47(2): 177-188
Shafiq, N.; Malhotra, S.; Bhasin, D.K.; Rana, S.; Siddhu, S.; Pandhi, P. 2005: Estimating the diagnostic accuracy of procalcitonin as a marker of the severity of acute pancreatitis: a meta-analytic approach Jop: Journal of the Pancreas 6(3): 231-237
Daghustani, M.; Alhammadi, A.; Merdad, K.; Ohlin, J.; Erhardt, F.; Ahlquist, M. 2011: Comparison between high concentration EDTA (24%) and low concentration EDTA (3%) with surfactant upon removal of smear layer after rotary instrumentation: a SEM study Swedish Dental Journal 35(1): 9-15
Surovikina, M.S.; Lapshina, I.M.; Maslikova, G.V.; Drozdova, G.A.; Vasil'ev, A.N. 1983: Method of estimating kininogenesis in blood plasma Biulleten' Eksperimental'noi Biologii i Meditsiny 95(5): 115-118
Broyer, M. 1989: Kidney transplantation in children--data from the EDTA registry. The EDTA Registry Committee Transplantation Proceedings 21(1 Pt 2): 1985-1988
Beheshti, I.; Wessels, L.M.; Eckfeldt, J.H. 1994: EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods Clinical Chemistry 40(11 Pt 1): 2088-2092
Canal, C.; Pellicer, R.; Rocha, C.I.; Calero, F.; Gracia, S.; Montañés, R.; Ballarín, J.; Bover, J. 2008: Tables estimating glomerular filtration rate from plasma creatinine Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(3): 317-324
Rahmati, K.; Åke Lernmark; Becker, C.; Foltyn, A.-Zadura; Larsson, K.; Sten-Ivarsson, A.; Carina Törn 2008: A Comparison of Serum and EDTA Plasma in the Measurement of Glutamic Acid Decarboxylase Autoantibodies (GADA) and Autoantibodies to Islet Antigen-2 (IA-2A) Using the RSR Radioimmunoassay (RIA) and Enzyme Linked Immunosorbent Assay (ELISA) Kits Clinical Laboratory 54(7-8): 227-235
Homann, C.; Garred, P.; Graudal, N.A.; Hasselqvist, P.; Christiansen, M.; Fagerhol, M.K.; Thomsen, A.C. 1996: Plasma calprotectin. a new prognostic marker of survival in alcoholic liver cirrhosis Ugeskrift for Laeger 158(21): 2980-2984
Niedzwicki, J.G.; Kouttab, N.M.; Mayer, K.H.; Carpenter, C.C.; Parks, R.E.; Abushanab, E.; Abernethy, D.R. 1991: Plasma adenosine deaminase2: a marker for human immunodeficiency virus infection Journal of Acquired Immune Deficiency Syndromes 4(2): 178-182
Gallacher, R.E.; Browning, M.C.; Fraser, C.G.; Wilkinson, S.P.; MacLennan, W.J. 1987: A method for simultaneously estimating plasma, erythrocyte, and leukocyte sodium, potassium, and magnesium: reference values and considerations from biological variation data Clinical Chemistry 33(8): 1326-1330
Rubio Caballero, M.; Nogués Biau, A.; Falguera Sacrest, M.; Puig Gatnau, T.; Lorente, L. 1998: Value of quantification of p24 antigen in plasma as a prognostic marker of survival in a cohort of 251 HIV-positive patients Anales de Medicina Interna 15(12): 647-649
Roberts, R.; Sobel, B.E. 1976: Elevated plasma MB creatine phosphokinase activity. a specific marker for myocardial infarction in perioperative patients Archives of Internal Medicine 136(4): 421-424
Vaubourdolle, M.; Chazouillères, O.; Briaud, I.; Legendre, C.; Serfaty, L.; Poupon, R.; Giboudeau, J. 1995: Plasma alpha-glutathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis C Clinical Chemistry 41(12 Part 1): 1716-1719
Vladisav Stefanović; Anti, S.ć 2004: Plasma Cell Membrane Glycoprotein 1 (PC-1): A Marker of Insulin Resistance in Obesity, Uremia and Diabetes Mellitus Clinical Laboratory 50(5-6): 271-278
Wilkes, H.C.; Meade, T.W.; Barzegar, S.; Foley, A.J.; Hughes, L.O.; Bauer, K.A.; Rosenberg, R.D.; Miller, G.J. 1992: Gemfibrozil reduces plasma prothrombin fragment F1 + 2 concentration, a marker of coagulability, in patients with coronary heart disease Thrombosis and Haemostasis 67(5): 503-506
Dahse, R.; Utting, M.; Werner, W.; Schimmel, B.; Claussen, U.; Junker, K. 2002: TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples International Journal of Oncology 20(1): 107-115
Fewster, C. 1990: Trapped in a stammer Nursing Times 86(7): 40-41
Friend, B. 1990: Trapped in Iraq Nursing Times 86(46): 16-17